| GO ID | Ontology | GO Term | Term Definition |
Proteins |
GO:0031645 | BP | negative regulation of neurological system process | Any process that stops, prevents, or reduces the frequency, rate or extent of a neurophysiological process. |
NPY2R |
GO:0031647 | BP | regulation of protein stability | Any process that affects the structure and integrity of a protein, altering the likelihood of its degradation or aggregation. |
AURKA, HDAC3, TADA3, KRAS, APOA2, TF, BCL2, LAMP2, MAPK1, NF2, SREBF1, LSS, NLRP5, CD81, PTEN, CDC42, ANK2, SOX4, PRKD1, CCAR2, RNF149, RNF128, LRRC46, VPS35, USP28, HDAC8, QRSL1, GNL3L, CDKN2AIP, DACT1, TOMM7, DPM3, HDAC6, PYCARD, STUB1, SUGT1, SH3GLB1 |
GO:0031648 | BP | protein destabilization | Any process that decreases the stability of a protein, making it more vulnerable to degradative processes or aggregation. |
PARK2, CTSH, BMP2, XBP1, SNCA, ID1, PLK1, PRKDC, MDM2, SIAH1, MYLIP, NCLN, SOX17, BTRC |
GO:0031649 | BP | heat generation | Any homeostatic process in which an organism produces heat, thereby raising its internal temperature. |
ADRB2, ADRB1, ADRB3 |
GO:0031651 | BP | negative regulation of heat generation | Any process that stops, prevents, or reduces the rate or extent of heat generation. |
ARRDC3 |
GO:0031652 | BP | positive regulation of heat generation | Any process that activates or increases the rate or extent of heat generation. |
ABAT, SLC27A1, APLN |
GO:0031658 | BP | negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle | Any process that stops, prevents, or reduces the frequency, rate or extent of cyclin-dependent protein serine/threonine kinase activity contributing to the G1/S transition of the cell cycle. |
PTEN |
GO:0031659 | BP | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle | Any process that activates or increases the frequency, rate or extent of cyclin-dependent protein serine/threonine kinase activity contributing to the G1/S transition of the cell cycle. |
EGFR, AKT1, ADAM17, PKD1, PKD2, RGCC |
GO:0031663 | BP | lipopolysaccharide-mediated signaling pathway | A series of molecular signals initiated by the binding of a lipopolysaccharide (LPS) to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. Lipopolysaccharides are major components of the outer membrane of Gram-negative bacteria, making them prime targets for recognition by the immune system. |
TLR4, IRAK2, RIPK2, TLR2, TGFB1, TNF, IL1B, LYN, CD14, CCL3, CCL2, CCL5, PTAFR, MAPK3, MAPK1, NOS3, CD6, AKT1, IRAK1, IL18, MAPK14, MTDH, SCARB1, PTPN22 |
GO:0031664 | BP | regulation of lipopolysaccharide-mediated signaling pathway | Any process that modulates the frequency, rate or extent of signaling in response to detection of lipopolysaccharide. |
CD55 |
GO:0031665 | BP | negative regulation of lipopolysaccharide-mediated signaling pathway | Any process that stops, prevents, or reduces the frequency, rate or extent of signaling in response to detection of lipopolysaccharide. |
SIGIRR, TRIB1, NFKBIL1 |
GO:0031666 | BP | positive regulation of lipopolysaccharide-mediated signaling pathway | Any process that activates or increases the frequency, rate or extent of signaling in response to detection of lipopolysaccharide. |
MIF, PRKCA, BMP6 |
GO:0031667 | BP | response to nutrient levels | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of nutrients. |
ACACB, FOXO3, MBD3, CST3, NTRK1, TH, PON1, SRD5A2, FOXO4, SORD, CHSY1, TPH2, PROX1 |
GO:0031668 | BP | cellular response to extracellular stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an extracellular stimulus. |
FOS, LYN, FOSL1, ITGA6, ADORA2B, CDKN1A, CDKN2B, SLC1A2, NR4A2, AES |
GO:0031669 | BP | cellular response to nutrient levels | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of nutrients. |
ULK1, IL6, ICAM1, PRKAA2, TXN2 |
GO:0031670 | BP | cellular response to nutrient | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus. |
HMOX1, XBP1, CDKN2B |
GO:0031672 | CC | A band | The dark-staining region of a sarcomere, in which myosin thick filaments are present; the center is traversed by the paler H zone, which in turn contains the M line. |
PPP1R12A, PPP1R12B, MYL4, HDAC4, MYL7, ANK2, KAT2B, MYH2 |
GO:0031673 | CC | H zone | A relatively pale zone traversing the center of the A band of a sarcomere, visible in relaxed muscle fibers; consists of the central portion of thick (myosin) filaments that are not overlapped by thin (actin) filaments. |
DST |
GO:0031674 | CC | I band | A region of a sarcomere that appears as a light band on each side of the Z disc, comprising a region of the sarcomere where thin (actin) filaments are not overlapped by thick (myosin) filaments; contains actin, troponin, and tropomyosin; each sarcomere includes half of an I band at each end. |
BIN1, NEBL, ALDOA, ACTC1, MTM1, ANKRD1, TTN, KAT2B |
GO:0031680 | CC | G-protein beta/gamma-subunit complex | The heterodimer formed by the beta and gamma subunits of a heterotrimeric G protein, which dissociates from the alpha subunit upon guanine nuclotide exchange. |
GNG5 |
GO:0031681 | MF | G-protein beta-subunit binding | Interacting selectively and non-covalently with a G-protein beta subunit. |
F2R, RGS7, F2RL1, RASD2 |
GO:0031683 | MF | G-protein beta/gamma-subunit complex binding | Interacting selectively and non-covalently with a complex of G-protein beta/gamma subunits. |
GNAI2, GNAI3, GNA11, ADORA1, GNAQ, GNAI1, GNAS, GNA12, GNAS |
GO:0031690 | MF | adrenergic receptor binding | Interacting selectively and non-covalently with an adrenergic receptor. |
C1QBP |
GO:0031694 | MF | alpha-2A adrenergic receptor binding | Interacting selectively and non-covalently with an alpha-2A adrenergic receptor. |
ADRB1, UCHL1 |
GO:0031697 | MF | beta-1 adrenergic receptor binding | Interacting selectively and non-covalently with a beta-1 adrenergic receptor. |
DLG4, MAGI2 |
GO:0031698 | MF | beta-2 adrenergic receptor binding | Interacting selectively and non-covalently with a beta-2 adrenergic receptor. |
GNAS, PDE4D, GNAS |
GO:0031699 | MF | beta-3 adrenergic receptor binding | Interacting selectively and non-covalently with a beta-3 adrenergic receptor. |
ADRB3, ARRDC3 |
GO:0031700 | MF | adrenomedullin receptor binding | Interacting selectively and non-covalently with an adrenomedullin receptor. |
ADM |
GO:0031702 | MF | type 1 angiotensin receptor binding | Interacting selectively and non-covalently with a type 1 angiotensin receptor. |
JAK2, AGT, GNB1, ARAP1 |
GO:0031703 | MF | type 2 angiotensin receptor binding | Interacting selectively and non-covalently with a type 2 angiotensin receptor. |
AGT |
GO:0031704 | MF | apelin receptor binding | Interacting selectively and non-covalently with an apelin receptor. |
APLN |
GO:0031707 | MF | endothelin A receptor binding | Interacting selectively and non-covalently with an endothelin A receptor. |
EDN1 |
GO:0031708 | MF | endothelin B receptor binding | Interacting selectively and non-covalently with an endothelin B receptor. |
EDN1, EDN2 |
GO:0031710 | MF | neuromedin B receptor binding | Interacting selectively and non-covalently with a neuromedin B receptor. |
NMB |
GO:0031711 | MF | bradykinin receptor binding | Interacting selectively and non-covalently with a bradykinin receptor. |
ACE, AGTR1 |
GO:0031715 | MF | C5L2 anaphylatoxin chemotactic receptor binding | Interacting selectively and non-covalently with a C5L2 anaphylatoxin chemotactic receptor. |
C3 |
GO:0031716 | MF | calcitonin receptor binding | Interacting selectively and non-covalently with a calcitonin receptor. |
RAMP1 |
GO:0031720 | MF | haptoglobin binding | Interacting selectively and non-covalently with a haptoglobin, any alpha2 globulin of blood plasma that can combine with free oxyhemoglobin to form a stable complex. |
HBB, HBA1 |
GO:0031726 | MF | CCR1 chemokine receptor binding | Interacting selectively and non-covalently with a CCR1 chemokine receptor. |
CCL3, CCL4, CCL5 |
GO:0031727 | MF | CCR2 chemokine receptor binding | Interacting selectively and non-covalently with a CCR2 chemokine receptor. |
CCL2 |
GO:0031729 | MF | CCR4 chemokine receptor binding | Interacting selectively and non-covalently with a CCR4 chemokine receptor. |
CCL5 |
GO:0031730 | MF | CCR5 chemokine receptor binding | Interacting selectively and non-covalently with a CCR5 chemokine receptor. |
CCL3, CCL4, CCL5, JAK1, STAT3 |
GO:0031731 | MF | CCR6 chemokine receptor binding | Interacting selectively and non-covalently with a CCR6 chemokine receptor. |
CCL20 |
GO:0031741 | MF | type B gastrin/cholecystokinin receptor binding | Interacting selectively and non-covalently with a type B gastrin/cholecystokinin receptor. |
CCKBR |
GO:0031748 | MF | D1 dopamine receptor binding | Interacting selectively and non-covalently with a D1 dopamine receptor. |
DLG4, GNAS, PTPN11, GNAS, VPS35 |
GO:0031752 | MF | D5 dopamine receptor binding | Interacting selectively and non-covalently with a D5 dopamine receptor. |
GNA12 |
GO:0031755 | MF | Edg-2 lysophosphatidic acid receptor binding | Interacting selectively and non-covalently with an Edg-2 lysophosphatidic acid receptor. |
RALA |
GO:0031764 | MF | type 1 galanin receptor binding | Interacting selectively and non-covalently with a type 1 galanin receptor. |
GAL |
GO:0031765 | MF | type 2 galanin receptor binding | Interacting selectively and non-covalently with a type 2 galanin receptor. |
GAL |
GO:0031766 | MF | type 3 galanin receptor binding | Interacting selectively and non-covalently with a type 3 galanin receptor. |
GAL |
GO:0031768 | MF | ghrelin receptor binding | Interacting selectively and non-covalently with a ghrelin receptor. |
GHRL |
GO:0031769 | MF | glucagon receptor binding | Interacting selectively and non-covalently with a glucagon receptor. |
GCG |
GO:0031770 | MF | growth hormone-releasing hormone receptor binding | Interacting selectively and non-covalently with a growth hormone-releasing hormone receptor. |
GHRH |
GO:0031773 | MF | kisspeptin receptor binding | Interacting selectively and non-covalently with a kisspeptin receptor. |
KISS1 |
GO:0031775 | MF | lutropin-choriogonadotropic hormone receptor binding | Interacting selectively and non-covalently with a lutropin-choriogonadotropic hormone receptor. |
ATP2A2 |
GO:0031780 | MF | corticotropin hormone receptor binding | Interacting selectively and non-covalently with a corticotropin hormone receptor. |
MRAP, MRAP2 |
GO:0031781 | MF | type 3 melanocortin receptor binding | Interacting selectively and non-covalently with a type 3 melanocortin receptor. |
POMC, MRAP, MRAP2 |
GO:0031782 | MF | type 4 melanocortin receptor binding | Interacting selectively and non-covalently with a type 4 melanocortin receptor. |
POMC, MRAP, MRAP2 |
GO:0031783 | MF | type 5 melanocortin receptor binding | Interacting selectively and non-covalently with a type 5 melanocortin receptor. |
MRAP, MRAP2 |
GO:0031800 | MF | type 3 metabotropic glutamate receptor binding | Interacting selectively and non-covalently with a type 3 metabotropic glutamate receptor. |
CALM2 |
GO:0031812 | MF | P2Y1 nucleotide receptor binding | Interacting selectively and non-covalently with a P2Y1 nucleotide receptor. |
DLG4 |
GO:0031821 | MF | G-protein coupled serotonin receptor binding | Interacting selectively and non-covalently with a metabotropic serotonin receptor. |
GNAI3, GNAI1 |
GO:0031826 | MF | type 2A serotonin receptor binding | Interacting selectively and non-covalently with a type 2A serotonin receptor. |
GNA11, GNAQ |
GO:0031838 | CC | haptoglobin-hemoglobin complex | A protein complex formed by the stable binding of a haptoglobin to hemoglobin. |
HP, HBB, HBA1 |
GO:0031848 | BP | protection from non-homologous end joining at telomere | A process that prevents non-homologous end joining at telomere, thereby ensuring that telomeres do not fuse. |
ACD, DCLRE1C |
GO:0031849 | MF | olfactory receptor binding | Interacting selectively and non-covalently with an olfactory receptor. |
REEP1 |
GO:0031852 | MF | mu-type opioid receptor binding | Interacting selectively and non-covalently with a mu-type opioid receptor. |
FLNA, GNAS, GNAS, WLS |
GO:0031856 | MF | parathyroid hormone receptor binding | Interacting selectively and non-covalently with a parathyroid hormone receptor. |
PTH |
GO:0031857 | MF | type 1 parathyroid hormone receptor binding | Interacting selectively and non-covalently with a type 1 parathyroid hormone receptor. |
PTH |
GO:0031860 | BP | telomeric 3' overhang formation | The formation of the single stranded telomeric 3' overhang, a conserved feature that ranges in length from 12 nt in budding yeast to approximately 500 nt in humans. |
NBN, MRE11A, RAD50 |
GO:0031867 | MF | EP4 subtype prostaglandin E2 receptor binding | Interacting selectively and non-covalently with an EP4 subtype prostaglandin E2 receptor. |
FEM1A |
GO:0031871 | MF | proteinase activated receptor binding | Interacting selectively and non-covalently with a proteinase activated receptor. |
PHB, PDCD6IP, BICD1 |
GO:0031901 | CC | early endosome membrane | The lipid bilayer surrounding an early endosome. |
WASH1, HSD17B6, STX7, SNX3, ATP9A, LRP6, STAM2, DKK1, SNX4, EGFR, HLA-B, ANXA1, NTRK1, FCGR1A, CFTR, HLA-E, HLA-G, HLA-A, HLA-F, EPS15, RAB5C, CLCN3, CLCN4, EPHB1, EPHA4, SNX16, RAB5B, B2M, RAC1, OCRL, CAV1, SNX1, MTMR2, EEA1, MARCH8, WLS, ZFYVE16, FGD2, APPL2, TMEM163, MARCH1, SNX19, SLC9A6, FCGR1B, STAM, SNX21, PMEPA1, EHD4, PLEKHF2, TMEM165, MTMR4, LAMP5, SNX6, PIKFYVE, SNX5 |
GO:0031902 | CC | late endosome membrane | The lipid bilayer surrounding a late endosome. |
VPS37C, GOSR2, NPC1, CHMP2A, VPS4B, HLA-DRA, NTRK1, ANXA2, ANXA6, LAMP2, HLA-DRB4, HLA-DMB, SLC11A1, SLC11A2, RAB7A, CLCN3, CLCN4, VAMP7, SNX16, RHOB, HLA-DRB3, IFITM3, PLD1, STARD3, MMD, HLA-DRB5, LAMTOR1, KIAA1324, VPS37A, MARCH1, SPPL2A, MITD1, ABCA5, ARL8A, MVB12A, OSBPL9, OSBPL11, TMEM59, AP5M1, CHMP4B, TMEM165, TMEM106B, ARL8B, TMEM9, VTI1B, PIKFYVE |
GO:0031904 | CC | endosome lumen | The volume enclosed by the membrane of an endosome. |
JAK2, INS, APOB, APP, PRLR, AP4S1 |
GO:0031905 | CC | early endosome lumen | The volume enclosed by the membrane of an early endosome. |
B2M, LNPEP |
GO:0031914 | BP | negative regulation of synaptic plasticity | A process that decreases synaptic plasticity, the ability of synapses to change as circumstances require. They may alter function, such as increasing or decreasing their sensitivity, or they may increase or decrease in actual numbers. |
CDK5 |
GO:0031915 | BP | positive regulation of synaptic plasticity | A process that increases synaptic plasticity, the ability of synapses to change as circumstances require. They may alter function, such as increasing or decreasing their sensitivity, or they may increase or decrease in actual numbers. |
PTGS2, CDC20, CPLX2 |
GO:0031929 | BP | TOR signaling | A series of molecular signals mediated by TOR (Target of rapamycin) proteins, members of the phosphoinositide (PI) 3-kinase related kinase (PIKK) family that act as serine/threonine kinases in response to nutrient availability or growth factors. |
RPS6, EIF4EBP1, EIF4EBP2, CCDC88A, LARP1, RICTOR, FLCN, RHEBL1, FNIP1 |
GO:0031931 | CC | TORC1 complex | A protein complex that contains at least TOR (target of rapamycin) and Raptor (regulatory-associated protein of TOR), or orthologs of, in complex with other signaling components. Mediates the phosphorylation and activation of S6K. In Saccharomyces, the complex contains Kog1p, Lst8p, Tco89p, and either Tor1p or Tor2p. |
LARP1, MLST8 |
GO:0031932 | CC | TORC2 complex | A protein complex that contains at least TOR (target of rapamycin) and Rictor (rapamycin-insensitive companion of TOR), or orthologs of, in complex with other signaling components. Mediates the phosphorylation and activation of PKB (also called AKT). In Saccharomyces, the complex contains Avo1p, Avo2p, Tsc11p, Lst8p, Bit61p, Slm1p, Slm2p, and Tor2p. |
SESN2, RPL23A, RICTOR, MAPKAP1, MLST8, PINK1 |
GO:0031933 | CC | telomeric heterochromatin | Heterochromatic regions of the chromosome found at the telomeres. |
ATRX, LRWD1 |
GO:0031936 | BP | negative regulation of chromatin silencing | Any process that stops, prevents, or reduces the frequency, rate or extent of chromatin silencing. |
HMGA1, ATAD2, ASF1A |
GO:0031941 | CC | filamentous actin | A two-stranded helical polymer of the protein actin. |
MYO1C, TPM1, TMSB15A, FLNA, RAC3, TMSB4X, ACTG1, TMSB10, TPM4, PKD2, IQGAP2, DPYSL3, FSCN1, LRRC16A, FERMT1, MYO6 |
GO:0031943 | BP | regulation of glucocorticoid metabolic process | Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving glucocorticoids. |
GAL, STUB1 |
GO:0031952 | BP | regulation of protein autophosphorylation | Any process that modulates the frequency, rate or extent of addition of the phosphorylation by a protein of one or more of its own residues. |
PPP2R5B |
GO:0031953 | BP | negative regulation of protein autophosphorylation | Any process that stops, prevents or decreases the rate of the phosphorylation by a protein of one or more of its own residues. |
JUN, ENPP1, ADIPOQ, CHP1, IMPACT, ERRFI1 |
GO:0031954 | BP | positive regulation of protein autophosphorylation | Any process that activates or increases the frequency, rate or extent of the phosphorylation by a protein of one or more of its own residues. |
NBN, PDGFB, INS, PDGFA, RAP2A, VEGFA, VEGFC, MRE11A, RAP2B, CALM2, NEK10, RAD50, PDGFD, PDGFC |
GO:0031957 | MF | very long-chain fatty acid-CoA ligase activity | Catalysis of the reaction: ATP + a very-long-chain carboxylic acid + CoA = AMP + diphosphate + an acyl-CoA; a very long-chain fatty acid is a fatty acid which has a chain length greater than C22. |
SLC27A2, ACSL4, SLC27A4, SLC27A1, SLC27A6 |
GO:0031959 | BP | mineralocorticoid receptor signaling pathway | Any series of molecular signals generated as a consequence of a mineralocorticoid binding to its receptor. |
JAK2, GPER1 |
GO:0031960 | BP | response to corticosteroid | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a corticosteroid hormone stimulus. A corticosteroid is a steroid hormone that is produced in the adrenal cortex. Corticosteroids are involved in a wide range of physiologic systems such as stress response, immune response and regulation of inflammation, carbohydrate metabolism, protein catabolism, blood electrolyte levels, and behavior. They include glucocorticoids and mineralocorticoids. |
GNRH1, COL1A1, NOTCH1 |
GO:0031965 | CC | nuclear membrane | Either of the lipid bilayers that surround the nucleus and form the nuclear envelope; excludes the intermembrane space. |
HAX1, CLIC1, IPO5, TOR1A, TNPO2, XPO1, SLC16A3, NUPL2, PLRG1, RANBP6, CDC14B, MRPS14, PDCD6, NUP155, NDUFB4, TNKS, CTDNEP1, EGFR, CST3, LMNA, GAPDH, ANXA4, ALOX5, BCL2, CDK4, TPR, HSD17B1, RCC1, LMNB1, NR4A1, CCND2, TSPO, GRK5, ADRA1A, ADRA1B, NUDT1, NUP62, PTGDS, RANGAP1, MRPL19, PSEN1, NUP153, RANBP2, SEPHS1, GNAQ, EMD, NUP107, NUTF2, YBX1, DMPK, AKAP6, LPIN1, KPNB1, WTAP, PCM1, RPS6KA2, TMEM176B, TMEM97, FAM76B, RRP12, CEP170, NSMF, CERS6, QSOX2, TMC6, MTDH, DGKH, NUP93, INTS1, CERS5, TMEM57, CNEP1R1, NUP35, CEP70, PUM2, RB1CC1, NUP210, IPO4, SYNE2, AHCTF1, NUP205, DNAJC1, PRICKLE1, CMTM3, RBM15, DCTN5, NDC1, DHRS4, PHF20, NUP58, NUP85, REPIN1, OSBPL8, OSBPL6, EPC1, AKIRIN1, CERS4, PLCB1, TXLNG, TMEM38B, DTL, ZNF224, HACD3, VAPA, SPAST, SUN2, HN1, MRTO4, NUP50, NRXN1, FZR1, MYO6, NPIPA1, WDR3, RNF6, KLHDC2, TNPO3, CEPT1, SLC30A1 |
GO:0031966 | CC | mitochondrial membrane | Either of the lipid bilayers that surround the mitochondrion and form the mitochondrial envelope. |
C7orf73, NDUFAB1, NDUFA1, NDUFA2, NDUFB6, ANXA1, CLU, PRKCA, SDHB, NME2, HSD3B2, PLN, ATXN3, SORD, OGDH, BNIP3, ETFDH, COX20, RNF144B, MAVS, OMA1, COX14, CARD19, GPER1, SFXN3, CCDC90B, REEP1, NDUFAF4, NDUFA13, TMEM14C, PEMT, BOK, MAPK8IP1, STARD13 |
GO:0031981 | CC | nuclear lumen | The volume enclosed by the nuclear inner membrane. |
SYNE2 |
GO:0031982 | CC | vesicle | Any small, fluid-filled, spherical organelle enclosed by membrane. |
CLIC1, PIK3C2A, DYNC1I1, TSPAN4, CASK, STX7, RIPK2, VPS26A, TF, ANXA1, GAPDH, ANXA2, GSTP1, MIF, PKM, IFNGR1, EZR, MUC1, RAB3B, CFL1, PLN, STOM, TKT, SERPINB3, LRPAP1, AKT1, TAGLN2, ECE1, GDI2, CD81, MYL6, SNAP25, RHOA, CALM2, RAB11A, GNB2, VAMP2, AHNAK, EPS8, DYNC1I2, PICALM, DCTN2, SNX1, GPRC5A, ARHGEF2, RAB39B, MVB12A, PACRG, ALS2, MUC4, CIB1, RAB34, CHMP4B, LGR6, ATP13A2, GPRC5C, SYBU, VAPA, VTI1B, RABGEF1, NRXN1, CORO1C, SLC6A14, LAMP3, MYO5A |
GO:0031985 | CC | Golgi cisterna | Any of the thin, flattened membrane-bounded compartments that form the central portion of the Golgi complex. |
SORL1, RAB34 |
GO:0031987 | BP | locomotion involved in locomotory behavior | Self-propelled movement of a cell or organism from one location to another in a behavioral context; the aspect of locomotory behavior having to do with movement. |
GPR37, ADGRL3, CLN6, FZD4, MYO5A |
GO:0031988 | CC | membrane-bounded vesicle | Any small, fluid-filled, spherical organelle enclosed by a lipid bilayer. |
BGLAP, BMP1, BMP6, SLC47A1 |
GO:0031990 | BP | mRNA export from nucleus in response to heat stress | The directed movement of mRNA from the nucleus to the cytoplasm during a heat stimulus, a temperature stimulus above the optimal temperature for the organism; in particular, a process that enables an organism withstand exposure to temperatures that would otherwise lethally impair poly(A)+ mRNA-nucleus export. |
POLR2D, TPR |
GO:0031994 | MF | insulin-like growth factor I binding | Interacting selectively and non-covalently with insulin-like growth factor I. |
ITGB3, INSR, ITGAV, IGF1R, IGFBP1, ITGB4, IGFBP3, IGFBP2, IGFBP4, ITGA6, IGFBP6, IGFBP5 |